Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 0.74 | (3.63) | (43.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 0.39 | (2.38) | (2.90)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.26 | (2.92) | (13.20)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 1.82 | (3.71) | (13.90)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 3.78 | (2.90) | (11.20)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
PDS: Q4 Results and Clinical Programs Update | 27-Mar-2025 | 16:46 | RNS |
PDS: VERSATILE-003 Phase 3 Clinical Trial | 07-Mar-2025 | 16:26 | RNS |
PDS: up to $22mn Registered Direct Offering | 27-Feb-2025 | 16:30 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 40.67p |
Change Today | -0.33p |
% Change | -0.81 % |
52 Week High | 76.50 |
52 Week Low | 40.00 |
Volume | 80,000 |
Shares Issued | 27.77m |
Market Cap | £11.29m |
Beta | 0.00 |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:36 | 40,000 @ 40.05p |
09:36 | 40,000 @ 40.00p |
You are here: research